Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,982
Closed -$3.02M 673
2026
Q1
$3.02M Buy
7,982
+1,522
+24% +$652K 0.01% 432
2025
Q4
$2.76M Sell
6,460
-1,069
-14% -$465K 0.01% 445
2025
Q3
$3.37M Buy
7,529
+2,535
+51% +$1.15M 0.01% 360
2025
Q2
$2.43M Buy
+4,994
New +$2.85M 0.01% 458
2025
Q1
Sell
-4,898
Closed -$2.59M 670
2024
Q4
$2.59M Sell
4,898
-284
-5% -$160K 0.01% 369
2024
Q3
$3.11M Buy
5,182
+1,157
+29% +$656K 0.02% 419
2024
Q2
$2.18M Sell
4,025
-70
-2% -$40.1K 0.01% 463
2024
Q1
$2.63M Sell
4,095
-574
-12% -$349K 0.01% 347
2023
Q4
$2.73M Sell
4,669
-1,051
-18% -$588K 0.02% 449
2023
Q3
$2.97M Sell
5,720
-886
-13% -$461K 0.02% 368
2023
Q2
$3.58M Sell
6,606
-122
-2% -$66.7K 0.03% 354
2023
Q1
$3.62M Buy
+6,728
New +$3.43M 0.02% 318

Other funds holding CHE

AGF Management's CHE Position: Q2 2026 in Review

AGF Management sold out of Chemed (CHE) in Q2 2026, closing a stake of 7,982 shares — an estimated $3.02M sold.

AGF Management first reported a position in CHE in Q1 2023 and held it in 12 quarters. The position peaked at $3.62M in Q1 2023. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • AGF Management reported no remaining Chemed position as of Q2 2026 after selling out during the quarter.
  • AGF Management sold 7,982 Chemed shares in Q2 2026, an estimated $3.02M.
  • AGF Management first reported a position in Chemed in Q1 2023 and held it in 12 quarters.
  • AGF Management's Chemed position peaked at $3.62M in Q1 2023.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on AGF Management's 13F filing for Q2 2026, filed 10 Aug 2026.